Can AI reinvent antibiotics we depend on?

Scientists discovered new antibiotics with the help of artificial intelligence (AI). These drugs are important because they can now kill dangerous germs that do not respond to normal treatments.

Such a disease gonorrhea – a sexually transmitted infection caused by bacteria (STI). It may spread from unprotected sexual contact and cause pain, unusual discharge and serious health problems if not treated.

Another is a kind of “super insect” bacteria that spread to hospitals. It can cause skin infections, slow healing wounds, fire, and sometimes life -threatening conditions. This is called “resistant, because ordinary antibiotics no longer work against it.

Since these germs become stronger than old drugs, doctors urgently need new drugs. With artificial intelligence, scientists can now search for such drugs faster and more effectively and give new hope to treat patients.

At the Sky News, Massachusetts Institute of Technology (MIT), they used AI to design more than 36 million possible drugs. The productive AI, which is a kind of computer program, can quickly create and test many options and help scientists identify fresh compounds that may function as strong antibiotics.

When tested for fighting germs on computers, the best candidates turned out to be very different from any antibiotic currently in use. They were also working in a new way by breaking the bacterial cell membrane.

A cell membrane is like a protective outer wall around each bacteria. Keeps the important parts of the germ safe and checks what is in and out. When this membrane is damaged or broken, bacteria cannot survive and eventually die. In this way, newly discovered drugs attack bacteria by breaking their protective shields by offering a new alternative to traditional treatments.

Antibiotics are drugs that kill bacteria, but some infections have become so strong that the usual drugs no longer work. Experts estimate that drug -resistant bacterial infections are linked to about five million deaths every year worldwide.

To fight this threat, scientists identified two promising compounds: DN1 for NG1 and MRSA for Gonorrhea. NG1 and DN1 names are not yet the name of the drug, but only the scientific codes given by researchers to monitor these early discoveries. These compounds are the first stage candidates, that is, after more tests, one day they can become real drugs to save lives.

Sky News is trying to develop these new compounds so that they can be used for more tests, an non -profit organization.

The study was published on Thursday, August 14, 2025 at the scientific magazine Cell.

“We are excited about the new opportunities that this project has brought to improve antibiotics by MIT Professor of MIT professor.

MIT researcher Aarti Krishnan, one of the chief writers, explained that the team did not want new compounds to resemble old antibiotics, because the germs learned how to resist them. Instead, they searched for less studied chemicals to find new ways to kill bacteria that could help solve the increasing drug resistance problem.

(The author of this article is a defense, aviation and political analyst based on Bengaluru. In addition, Add Engineering components, India, PVT. Ltd, Add Engineering GmbH is a subsidiary of Germany.

(Waiver: The views mentioned above are the author itself and do not reflect that of DNA)